Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients.
Maria-Filothei LazaridouEvamaria GonschorekChiara MassaMichael FriedrichDiana HandkeAnja MuellerSimon Jasinski-BergnerReinhard DummerPeter KoelblingerBarbara SeligerPublished in: Oncoimmunology (2020)
Ab: antibody; ACTB: β-actin; APM: antigen processing and presentation machinery; ATCC: American tissue culture collection; β2-m: β2-microglobulin; BSA: bovine serum albumin; CTL: cytotoxic T lymphocyte; FCS: fetal calf serum; FFL: firefly luciferase; FFPE: formalin-fixed paraffin-embedded; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; HC: heavy chain; HLA: human leukocyte antigen; HLA-I: HLA class I; HRP: horseradish peroxidase; IFN: interferon; im-miR: immune modulatory miRNA; LMP: low molecular weight protein; luc: luciferase; MFI: mean fluorescence intensity; MHC: major histocompatibility complex; miR: microRNA; NC: negative control; NK: natural killer; NSCLC: non-small cell lung carcinoma; OS: overall survival; PBMC: peripheral blood mononuclear cells; RBP: RNA-binding proteins; RL: Renilla; RLU: relative light units; TAP: transporter associated with antigen processing; tpn: tapasin; UTR: untranslated region.
Keyphrases
- cell proliferation
- long non coding rna
- end stage renal disease
- long noncoding rna
- ejection fraction
- small cell lung cancer
- dendritic cells
- endothelial cells
- newly diagnosed
- chronic kidney disease
- single cell
- peripheral blood
- peritoneal dialysis
- prognostic factors
- cell therapy
- immune response
- high intensity
- stem cells
- bone marrow
- case report
- mesenchymal stem cells
- single molecule
- nitric oxide
- amino acid
- cell migration
- quantum dots
- pluripotent stem cells